Sees FY26 adjusted EBITDA $7M-$15M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health price target lowered to $17 from $22 at Barclays
- OMDA Upcoming Earnings Report: What to Expect?
- Omada Health expands platform to include cholesterol management
- Omada Health: Sentiment-Driven Sell-Off Creates Compelling Entry Point Amid Accelerating Growth and Limited Policy Risk
- Omada Health: Strong 2025 Finish, GLP-1 Tailwinds, and Attractive 2026 Valuation Upside Support Reiterated Buy Rating